Direct Meds GLP-1 Offers US is a managed-approval CPA campaign focused on the US GLP-1 weight loss and telehealth market. The offer is available through Vexio for qualified partners who can drive compliant, high-intent traffic through approved promotional channels.
With a strong CPA payout and partner tracking, this campaign may be a good fit for publishers, affiliates, email partners, native media buyers, and performance marketers with relevant health, wellness, weight loss, or telehealth audiences in the United States.
Because this is a health-related campaign, partners must follow all offer terms, traffic-source rules, and applicable advertising requirements. Promotional content should avoid exaggerated claims, guaranteed weight-loss results, misleading medical language, unauthorized brand bidding, or unapproved creatives. Vexio may review traffic sources, promotional methods, GEO fit, and compliance before approving access.
